These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29435270)

  • 1. Roles of toll-like receptors: From inflammation to lung cancer progression.
    Gu J; Liu Y; Xie B; Ye P; Huang J; Lu Z
    Biomed Rep; 2018 Feb; 8(2):126-132. PubMed ID: 29435270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.
    Bhattacharya D; Yusuf N
    Int J Breast Cancer; 2012; 2012():716564. PubMed ID: 22295250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Toll-Like Receptors for Cancer Therapy.
    Braunstein MJ; Kucharczyk J; Adams S
    Target Oncol; 2018 Oct; 13(5):583-598. PubMed ID: 30229471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.
    Szczepański M; Stelmachowska M; Stryczyński L; Golusiński W; Samara H; Mozer-Lisewska I; Zeromski J
    Eur Arch Otorhinolaryngol; 2007 May; 264(5):525-30. PubMed ID: 17165086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.
    Zou H; Wang WK; Liu YL; Braddock M; Zheng MH; Huang DS
    Expert Opin Ther Targets; 2016 Sep; 20(9):1127-35. PubMed ID: 26998881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.
    Yu L; Wang L; Chen S
    Biochim Biophys Acta; 2013 Apr; 1835(2):144-54. PubMed ID: 23232186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-Like Receptors Signaling in the Tumor Microenvironment.
    McCall KD; Muccioli M; Benencia F
    Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Toll-Like Receptors in Hematopoietic Malignancies.
    Monlish DA; Bhatt ST; Schuettpelz LG
    Front Immunol; 2016; 7():390. PubMed ID: 27733853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.
    Tran TH; Tran TTP; Truong DH; Nguyen HT; Pham TT; Yong CS; Kim JO
    Acta Biomater; 2019 Aug; 94():82-96. PubMed ID: 31129358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.
    Luddy KA; Robertson-Tessi M; Tafreshi NK; Soliman H; Morse DL
    Front Immunol; 2014; 5():429. PubMed ID: 25368611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of toll-like receptors in lung cancer.
    Yang LS; Wu WS; Zhang F; Jiang Y; Fan Y; Fang HX; Long J
    J Recept Signal Transduct Res; 2014 Oct; 34(5):342-4. PubMed ID: 24641697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
    Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
    Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers.
    Chandrasekar SA; Palaniyandi T; Parthasarathy U; Surendran H; Viswanathan S; Wahab MRA; Baskar G; Natarajan S; Ranjan K
    Pathol Res Pract; 2023 Aug; 248():154673. PubMed ID: 37453359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
    Ohadian Moghadam S; Nowroozi MR
    Scand J Immunol; 2019 Dec; 90(6):e12818. PubMed ID: 31448424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent patents in Toll-like receptor pathways and relevance to cancer.
    Kimbro K; Parker S
    Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):189-95. PubMed ID: 19522696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.